Taiwan Bio Therapeutics Co., Ltd. (6892)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
24. 55
-0.45
-1.8%
NT$
3.12B Market Cap
- P/E Ratio
- Div Yield
39,803 Volume
- Eps
NT$ 25
Previous Close Want to track 6892 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Taiwan Bio Therapeutics Co., Ltd. (6892) Statistics
Valuation metrics
Market Cap 3.12B
Enterprise value 2.09B
Trailing P/E (ttm) -10.7
Forward P/E -
PEG ratio 0.3
Price/Sales (ttm) 91.66
Price/Book (mrq) 2.29
Enterprise Value/Revenue 83.67
Enterprise Value/EBITDA -16.49
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 92.3K
Average volume (90 days) 145.09K
Price summary
52-Week low 23.55
52-Week high 34.7
Beta -
50-Day moving average 26.3
200-Day moving average 27.07
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 207:200
Last split Date 27 Apr 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -7.69%
Operating margin -7.35%
Operational effectiveness
Return on assets -0.15%
Return on equity -0.2%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.3
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.28
Total debt (mrq) -
Total Debt/Equity (mrq) 0.37
Current ratio (mrq) 8.15%
Book value per share (mrq) 10.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
